The North Carolina State Grange
serves as a family-oriented organization committed to serving its members through a variety of programs and services. The Grange promotes agriculture as an essential industry for our economy. Grassroots involvement in governmental issues is promoted through the development of legislative policy and through the encouragement of political participation.
@ncgrangeNCSGrangeConversations Contributors (Source: PHRMA)
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Cynthia A. Bens - Older Americans
One of the great achievements of the last 100 years has been the significant increase in the lifespan of Americans. By 2050 it is estimated that 20 percent of the total U.S. population will be over the age of 65. While this is something to celebrate, there is also a downside. With the expected growth of the aging population, we expect to see a significant rise in many chronic diseases where age is a major risk factor.
The effects age-related chronic disease are immense both to the person experiencing them and society. Diseases like Alzheimer’s disease, frailty, diabetes, cardiovascular disease and stroke contribute t...
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Cynthia A. Bens - Elder Americans
One of the great achievements of the last 100 years has been the significant increase in the lifespan of Americans. By 2050 it is estimated that 20 percent of the total U.S. population will be over the age of 65. While this is something to celebrate, there is also a downside. With the expected growth of the aging population, we expect to see a significant rise in many chronic diseases where age is a major risk factor.
The effects age-related chronic disease are immense both to the person experiencing them and society. Diseases like Alzheimer’s disease, frailty, diabetes, cardiovascular disease and stroke contribute t...
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Cynthia A. Bens
Vice President, Public PolicyCynthia Bens is the Vice President of Public Policy at the not-for-profit Alliance for Aging Research in Washington, D.C. In this capacity, Ms. Bens is responsible for guiding the organization’s federal policy work, representing the Alliance in multiple national coalitions, and directing all aspects of the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) and Aging in Motion (AIM) coalitions. Ms. Bens sits on the Alliance for a Stronger FDA Board of Directors and is a Founding Executive Committee Member of Friends of the National Institute on Aging (FoNIA). She has served on the...
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
As Americans live longer, how can we tackle aging as a major risk factor for chronic disease?
Bob Blancato - Older Americans
Submitted by Sabrina on Tue, 06/17/2014 - 11:10
To tackle aging as a major risk factor for chronic disease, we need to develop a more aggressive public-private investment strategy in prevention and health promotion.
On the private side, as the Medicines in Development for Older Americans report shows, biopharmaceutical research companies are developing over 400 medications for the top chronic diseases to allow these older adults to live a better and in some cases longer life.
Share
Email
Print
...
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Bob Blancato - Older Americans
To tackle aging as a major risk factor for chronic disease, we need to develop a more aggressive public-private investment strategy in prevention and health promotion.
On the private side, as the Medicines in Development for Older Americans report shows, biopharmaceutical research companies are developing over 400 medications for the top chronic diseases to allow these older adults to live a better and in some cases longer life.
On the public side, it is about investing in federal programs such as nutrition. For example, studies have shown that the top three chronic conditions (hypertension, diabetes and high choles...
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Bob Blancato - Elder Americans
To tackle aging as a major risk factor for chronic disease, we need to develop a more aggressive public-private investment strategy in prevention and health promotion.
On the private side, as the Medicines in Development for Older Americans report shows, biopharmaceutical research companies are developing over 400 medications for the top chronic diseases to allow these older adults to live a better and in some cases longer life.
On the public side, it is about investing in federal programs such as nutrition. For example, studies have shown that the top three chronic conditions (hypertension, diabetes and high choles...
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Patient Reported Outcomes as a Means to Reaching Effective Quality Measurement
A recent Roundtable in Washington D.C. underscored why, with the growing focus on value-based payment in health care, it’s more important than ever to focus on the patient. We can’t advance patient-centered care if we aren’t measuring and incentivizing what matters to patients. We have begun to see this shift in the premarket arena via patient-focused drug development and in comparative effectiveness research at the Patient-Centered Outcomes Research Institute. It’s time for the same shift to occur in provider value-based payment.
The patient’s preferences and feedback are a critical aspect in achieving value. On...
Source: PHRMA - June 17, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Salvatore Alesci on Cancer Research
Like both sides of a coin, there are two sides in the battle against cancer. We are making huge strides in preventing, slowing and in some cases beating many forms of cancer, but there are still considerable roadblocks to reaching our ultimate goal of a world free from cancer.
Let’s start with the good news. For most of the 20th Century a diagnosis of cancer was seen as a death sentence – but no longer. Our early understanding of the related biological processes was relatively minimal as researchers initially believed cancer was a monolithic disease. Today, however, researchers in academia, the government and biopharma...
Source: PHRMA - June 16, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Colon Cancer Alliance - high out-of-pocket costs
The Colon Cancer Alliance is committed to providing support and empowerment to those who are affected by colon cancer. This is why we’re actively addressing the patient impact of high out-of-pocket costs for medicine. Due to increased costs, patients are making decisions about treatment based on financial implication as opposed to selecting the best treatment path to address their current condition. The Affordable Care Act and Health Insurance Exchanges were intended to address the need for affordable care. The new Avelere study supports the patient stories we often hear. High copays and deductibles can create a fina...
Source: PHRMA - June 13, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Colon Cancer Alliance
The Colon Cancer Alliance, Inc. is a not-for-profit 501(c)3 corporation (EIN 86-0947831). We are the leading national patient advocacy organization dedicated to increasing screening rates and survivorship. Ask the hundreds of thousands of people we help each year and they will tell you we are an active, caring community. We know first-hand how devastating this cancer can be. We also know it doesn’t have to be this way.
CCAllianceColonCancerAlliance?ref=tsConversations ContributorsCompany: Colon Cancer Alliance (Source: PHRMA)
Source: PHRMA - June 13, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Bob Blancato on Exchanges
This study exposes a genuine flaw in a key part of the Act which especially impacts the 25 percent of enrollees in exchanges who are between the ages of 55 and 64. People as they age find their prescription drug costs rise, in part due to increases in chronic conditions. These pre-Medicare individuals may find that signing up for silver exchange plans represented a false economy. While it is true that they may pay less for monthly premiums than gold or platinum exchange plans, they may pay at least several times more in co-pays for prescription drugs, especially for drugs treating chronic conditions. This situation needs...
Source: PHRMA - June 13, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Bob Blancato
Executive DirectorBob Blancato is the Executive Director of the National Association of Nutrition and Aging Services Programs. He is also President of Matz, Blancato and Associates. He is the National Coordinator of the 3000-member Elder Justice Coalition. Bob has more than 20 years of federal government service, including 13 years on the senior staff of the House Select Committee on Aging and a presidential appointment to be the Executive Director of the 1995 White House Conference on Aging. Bob is currently on the Boards of the American Society on Aging and the National Council on Aging. In December 2012, Bob was reap...
Source: PHRMA - June 13, 2014 Category: Pharmaceuticals Authors: Julie Source Type: news
Lawrence A. LaMotte - high out-of-pocket costs
YouTube ID: iudpr_XVfe0 (Source: PHRMA)
Source: PHRMA - June 12, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
Lawrence A. LaMotte
Vice President, Public PolicyLarry joined the Immune Deficiency Foundation (IDF) in 2009 after a successful career in business and as an elected official in the General Assembly of the State of Maryland.
Larry’s interest in health policy issues crystallized while serving 12 years as an elected official. In that capacity, Larry served on the Environmental Matters Committee as Chairman of the Subcommittee on Health and Environment. Virtually all health and environmental legislation came before his subcommittee.
After voluntarily leaving the legislature, Larry was named Vice President of Business Development and Marketing o...
Source: PHRMA - June 12, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news
